prof. dr. Sandra Heskamp

People Sandra Heskamp

Profile

prof. dr. Sandra Heskamp



About Sandra Heskamp

Sandra Heskamp studied Biomedical Sciences at the Radboud University of Nijmegen. In 2009, she graduated in two master’s: Epidemiology and Biostatistics and Human Pathobiology. That same year she started her PhD project Molecular Imaging of Receptor Tyrosine Kinases in Cancer, a collaborative project between the department of Nuclear Medicine and Medical Oncology. During her PhD she also participated in a European consortium (Innovative Medicines Initiative) that investigated the potential of diffusion weighted MRI and [18F]FLT as early biomarkers of treatment response in cancer. In addition, she worked as a visiting researcher at the Technical University Munich to study the potential of alpha-emitting radionuclides for cancer treatment. In June 2014 she obtained her PhD and she started working as a post-doc at the department of Medical Imaging at the Radboudumc. Here, she started her own research group focusing on nuclear imaging and therapy in immuno-oncology. Together with scientists in her group she develops novel radiotracers to visualize tumor cells and their immune-microenvironment, in order to study the biology of cancer in an in vivo manner. Futhermore, these tracers are labeled with therapeutic radionuclides to specifically deliver a high dose of radiation to a tumor. Her current research focuses on the radiobiological and immunological effects of radiation on tumor cells and their immune-microenvironment. 


Position(s)

  • full professor

Personal prizes & awards

  • 2023 - NWO Perspectief Grant: "Understanding the radiobiology of therapeutic medical radionuclides"
  • 2022 - Supervisor of the Year Award - Radboud Institute for Molecular Life Sciences
  • 2021 - VIDI personal grant: "Carbonic Anhydrase IX Targeted Alpha Therapy for selective killing of hypoxic therapy resistant cancer cells"
read more

Personal prizes & awards

  • 2023 - NWO Perspectief Grant: "Understanding the radiobiology of therapeutic medical radionuclides"
  • 2022 - Supervisor of the Year Award - Radboud Institute for Molecular Life Sciences
  • 2021 - VIDI personal grant: "Carbonic Anhydrase IX Targeted Alpha Therapy for selective killing of hypoxic therapy resistant cancer cells"
  • 2019 - X² Ambition Award: This award is intended young, ambitious women who show exemplary behaviour within Radboudumc, but also outside their organization.
  • 2017 - EANM Eckert & Ziegler Abstract Award 2017 for “Monitoring tumor PD-L1 expression with microSPECT/CT during radiotherapy”
  • 2016 - VENI personal grant: "Towards better patient selection for immune checkpoint inhibitor therapy for cancer: imaging of the PD-L1 and PD-1 pathway"
  • 2016 - KWF Bas Mulder Young Investigator Grant: "Towards personalized use of immune checkpoint inhibitors by imaging of the PD-1/PD-L1 pathway"
  • 2015 - SNMMI Nuclear Oncology Council Young Investigator Award for “Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenografts”
  • 2013 - Travel grant Dutch Cancer Society (KWF) to perform a 3-month research project at the Technische Universität München, Germany
  • 2012 - Dr. I.B.M. Frye Stipendium, scholarship for talented female PhD students, awarded by the Radboud University Nijmegen

Additional Functions

  • Chair of Dutch Society for Clinical Radiochemistry
  • Co-chair of the Onco-Immunology & Therapy study group of the European Society of Molecular Imaging
  • Editorial board member of Nederlands tijdschrift voor Nucleaire Geneeskunde
read more

Additional Functions

  • Chair of Dutch Society for Clinical Radiochemistry
  • Co-chair of the Onco-Immunology & Therapy study group of the European Society of Molecular Imaging
  • Editorial board member of Nederlands tijdschrift voor Nucleaire Geneeskunde
  • Editorial board member European Journal of Molecular Imaging and Nuclear Medicine Research
  • Chair Radboud Technology Center Imaging
  • Member of the Central Animal Facility advisory board
  • Member Scientific Advisory Board NRG|PALLAS
  • Co-founder, shareholder and scientific advisor for Aurelius Therapeutics B.V. (Radboudumc spin-off)

Social media


Research position

  • full professor